Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Co. stock logo
BSX
Boston Scientific
$73.07
-0.5%
$68.68
$48.35
$74.39
$107.20B0.776.56 million shs1.71 million shs
BYN
Banyan Acquisition
$3.03
+0.7%
$4.11
$7.11
$13.50
$34.07M0.0363,314 shs19,767 shs
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
$10.75
+0.4%
$10.69
$9.63
$12.12
$95.18M0.036,162 shs809 shs
QMX
QMX Gold
C$0.29
+1.8%
C$0.29
C$0.09
C$0.38
C$114.56MN/A2.28 million shs93,800 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Co. stock logo
BSX
Boston Scientific
+1.21%+2.18%+7.10%+12.53%+38.23%
BYN
Banyan Acquisition
-72.20%+1.00%-2.57%-9.55%-70.61%
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
+0.37%+0.37%+0.84%+1.90%+7.93%
QMX
QMX Gold
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.2062 of 5 stars
2.53.00.04.21.42.52.5
BYN
Banyan Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
QMX
QMX Gold
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Co. stock logo
BSX
Boston Scientific
2.95
Moderate Buy$75.092.77% Upside
BYN
Banyan Acquisition
N/AN/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
N/AN/AN/AN/A
QMX
QMX Gold
N/AN/AN/AN/A

Current Analyst Ratings

Latest OSI, BSX, QMX, and BYN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $78.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$79.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$63.00 ➝ $73.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$78.00 ➝ $82.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$73.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $90.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$80.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$72.00 ➝ $78.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00
(Data available from 5/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Co. stock logo
BSX
Boston Scientific
$14.24B7.53$2.91 per share25.09$13.33 per share5.48
BYN
Banyan Acquisition
N/AN/AN/AN/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
N/AN/AN/AN/A($1.83) per shareN/A
QMX
QMX Gold
N/AN/AC$0.02 per share16.11C$0.09 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.59B$1.1961.4027.892.5112.06%16.39%9.08%7/25/2024 (Estimated)
BYN
Banyan Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
-$2.39MN/A0.00N/AN/AN/A-7.22%N/A
QMX
QMX Gold
N/A-C$0.01N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
BYN
Banyan Acquisition
N/AN/AN/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
N/AN/AN/AN/AN/A
QMX
QMX Gold
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.47
1.66
1.14
BYN
Banyan Acquisition
N/AN/AN/A
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
N/A
0.04
0.04
QMX
QMX Gold
7.71
1.45
1.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Co. stock logo
BSX
Boston Scientific
89.07%
BYN
Banyan Acquisition
13.38%
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
6.83%
QMX
QMX Gold
N/A

Insider Ownership

CompanyInsider Ownership
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.50%
BYN
Banyan Acquisition
22.80%
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
19.80%
QMX
QMX Gold
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
48,0001.47 billion1.46 billionOptionable
BYN
Banyan Acquisition
N/A11.24 million8.68 millionNot Optionable
Osiris Acquisition Corp. stock logo
OSI
Osiris Acquisition
2,0218.85 million7.10 millionNot Optionable
QMX
QMX Gold
N/A395.03 millionN/ANot Optionable

OSI, BSX, QMX, and BYN Headlines

SourceHeadline
Disney CEO Bob Iger on joint sports streaming venture: We want to serve sports fans in multiple waysDisney CEO Bob Iger on joint sports streaming venture: We want to serve sports fans in multiple ways
msn.com - April 4 at 8:14 PM
Mercury exposure widespread among Yanomami tribe in Amazon, report findsMercury exposure widespread among Yanomami tribe in Amazon, report finds
msn.com - April 4 at 8:14 PM
Tribute paid to father-of-four, Jonathan Nyashanu, who was killed by drink driver in Earsham crashTribute paid to father-of-four, Jonathan Nyashanu, who was killed by drink driver in Earsham crash
msn.com - February 29 at 12:58 PM
Holiday Gift Guide for Star Trek FansHoliday Gift Guide for Star Trek Fans
msn.com - December 15 at 9:13 PM
New bill suggests expanded angel investors and funds for start-ups in the U.S.New bill suggests expanded angel investors and funds for start-ups in the U.S.
msn.com - November 16 at 6:04 PM
Hearing will take place in religious leaders lawsuit challenging Missouri abortion banHearing will take place in religious leaders' lawsuit challenging Missouri abortion ban
caledonianrecord.com - November 16 at 8:03 AM
Is Buying A Home A Bad Investment - Mr Williams Gave The ClassIs Buying A Home A Bad Investment - Mr Williams Gave The Class
next-finance.net - July 21 at 8:50 AM
15 Most Valuable Star Trek Memorabilia15 Most Valuable Star Trek Memorabilia
msn.com - June 23 at 9:49 AM
15 Most Valuable Star Trek Memorabilia15 Most Valuable Star Trek Memorabilia
msn.com - June 23 at 9:49 AM
Foremost Lithium Makes Gold Discovery On Maiden Jean Lake Drill Program With Near Surface Intercepts of 7.50 g/t Gold on Over 7.66 MetresForemost Lithium Makes Gold Discovery On Maiden Jean Lake Drill Program With Near Surface Intercepts of 7.50 g/t Gold on Over 7.66 Metres
markets.buffalonews.com - June 6 at 1:07 PM
Xander Resources Completes Shares for Debt TransactionsXander Resources Completes Shares for Debt Transactions
thenewswire.com - April 15 at 12:15 AM
Canadian men face Curacao in their first game since World Cup in QatarCanadian men face Curacao in their first game since World Cup in Qatar
msn.com - March 24 at 9:21 PM
Growing risk Australia will fall into a recession after interest rate hikesGrowing risk Australia will fall into a recession after interest rate hikes
9news.com.au - February 10 at 10:32 AM
COPD Gold GuidelinesCOPD Gold Guidelines
healthline.com - January 21 at 7:23 AM
Xander Resources Closes $1,304,575 of Non-Brokered Private PlacementsXander Resources Closes $1,304,575 of Non-Brokered Private Placements
juniorminingnetwork.com - December 22 at 8:11 AM
Seattle Kraken forward Shane Wright joins Canadas world junior teamSeattle Kraken forward Shane Wright joins Canada's world junior team
msn.com - December 8 at 3:38 PM
Black Swan Graphene to add seasoned mining CEO Brad Humphrey as independent directorBlack Swan Graphene to add seasoned mining CEO Brad Humphrey as independent director
proactiveinvestors.com - November 9 at 2:00 PM
Black Swan Graphene Nominates Brad Humphrey for Election as Independent Director at Upcoming Annual General MeetingBlack Swan Graphene Nominates Brad Humphrey for Election as Independent Director at Upcoming Annual General Meeting
technews.tmcnet.com - November 9 at 8:59 AM
EV Technology Group Ltd.EV Technology Group Ltd.
wsj.com - September 17 at 11:38 PM
STAR TREK Silver Metallic InsigniaSTAR TREK Silver Metallic Insignia
marieclaire.fr - September 15 at 9:18 PM
New exploration company sniffing around old mine sitesNew exploration company sniffing around old mine sites
winnipegfreepress.com - August 16 at 10:54 AM
Xander Resources 2022 Recap & Exploration Plan UpdateXander Resources 2022 Recap & Exploration Plan Update
juniorminingnetwork.com - July 27 at 9:03 AM
1287390 B.C. Ltd. Announces Update on Proposed Business Combination Transaction with NiCAN Limited1287390 B.C. Ltd. Announces Update on Proposed Business Combination Transaction with NiCAN Limited
finance.yahoo.com - July 4 at 6:02 PM
Jennifer JonesJennifer Jones
sportsmole.co.uk - June 14 at 10:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Boston Scientific logo

Boston Scientific

NYSE:BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Banyan Acquisition

NYSE:BYN
Banyan Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on identifying business combination targets in the foodservice industry. The company was incorporated in 2021 and is based in Northbrook, Illinois.
Osiris Acquisition logo

Osiris Acquisition

NYSE:OSI
Osiris Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. Osiris Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

QMX Gold

CVE:QMX
QMX Gold Corporation, a junior exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada. It primarily explores for gold and base metal deposits. The company holds a portfolio of properties covering approximately 200 square kilometers of the Val d'Or Mining Camp in the Abitibi district of Québec. The company was formerly known as Alexis Minerals Corporation and changed its name to QMX Gold Corporation in June 2012. QMX Gold Corporation was incorporated in 1988 and is headquartered in Toronto, Canada. As of April 7, 2021, QMX Gold Corporation operates as a subsidiary of Eldorado Gold Corporation.